Immunotherapy of multiple sclerosis: Where are we? Where should we go?

Roland Martin, Claus Steffen Stürzebecher, Henry F. McFarland

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)785-788
Number of pages4
JournalNature Immunology
Volume2
Issue number9
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Immunological Models
Self Tolerance
Interferon-beta
Genetic Predisposition to Disease
Autoimmunity
Immunotherapy
Multiple Sclerosis
Tumor Necrosis Factor-alpha
T-Lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Immunotherapy of multiple sclerosis : Where are we? Where should we go? / Martin, Roland; Stürzebecher, Claus Steffen; McFarland, Henry F.

In: Nature Immunology, Vol. 2, No. 9, 2001, p. 785-788.

Research output: Contribution to journalArticle

Martin, R, Stürzebecher, CS & McFarland, HF 2001, 'Immunotherapy of multiple sclerosis: Where are we? Where should we go?', Nature Immunology, vol. 2, no. 9, pp. 785-788. https://doi.org/10.1038/ni0901-785
Martin, Roland ; Stürzebecher, Claus Steffen ; McFarland, Henry F. / Immunotherapy of multiple sclerosis : Where are we? Where should we go?. In: Nature Immunology. 2001 ; Vol. 2, No. 9. pp. 785-788.
@article{66d5320c941a457782a899246234aaf6,
title = "Immunotherapy of multiple sclerosis: Where are we? Where should we go?",
author = "Roland Martin and St{\"u}rzebecher, {Claus Steffen} and McFarland, {Henry F.}",
year = "2001",
doi = "10.1038/ni0901-785",
language = "English (US)",
volume = "2",
pages = "785--788",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Immunotherapy of multiple sclerosis

T2 - Where are we? Where should we go?

AU - Martin, Roland

AU - Stürzebecher, Claus Steffen

AU - McFarland, Henry F.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0035554905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035554905&partnerID=8YFLogxK

U2 - 10.1038/ni0901-785

DO - 10.1038/ni0901-785

M3 - Article

C2 - 11526386

AN - SCOPUS:0035554905

VL - 2

SP - 785

EP - 788

JO - Nature Immunology

JF - Nature Immunology

SN - 1529-2908

IS - 9

ER -